Analyst consensus rating
Sanofi Analyst Rating: Buy
Direct answer
Sanofi's consensus rating is Buy.
9 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $54.92.
Forecast evidence checked November 21, 2026.
Get free Sanofi email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $46.52
- Average price target
- $54.92
- High price target
- $63.00
- Low price target
- $45.00
- Low target gap
- -3.3%
- Target upside
- +18.1%
- High target gap
- +35.4%
- Target range width
- 38.7%
- Consensus rating
- Buy
- Analysts
- 9
- Evidence date
- November 21, 2026
- Valid through
- November 28, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Sanofi?
Sanofi has a verified Buy consensus. The same dataset has an average price target of $54.92.
How far are Sanofi's low and high targets from the recorded price?
The low target implies -3.3%, while the high target implies +35.4%.
How many analysts are included in Sanofi's consensus?
The verified consensus includes 9 analysts.
How is Sanofi's target upside or downside calculated?
The average target of $54.92 is divided by the recorded price of $46.52, then one is subtracted to produce +18.1%. This does not guarantee a future return.
When was Sanofi's analyst forecast verified?
The data was verified on 2026-11-21. The dataset is valid through 2026-11-28.